Nearly three weeks after two suspicious deaths were reported following complications allegedly linked to the administration ...

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Researchers at the University of Washington have developed a rapid test that quickly detects hepatitis C, but insurance ...

Zenas BioPharma said on Monday its experimental drug cut the risk of disease flare-ups in a late-stage study of patients with a rare immune system-related condition that can damage organs over time.

The treatment also prevented the development of arthritis after knee injuries such as ACL tears often experienced by athletes ...

Halozyme Therapeutics Inc. and Skye Bioscience Inc. have entered a non-exclusive global collaboration and license agreement.

A one-dose oral drug called zoliflodacin has proven highly effective against gonorrhoea in a major international trial. The ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...

Naltrexone has long been used to treat alcohol use disorder. Now it’s gaining attention as a tool for people who want to cut ...

Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimabSAN ...

A treatment that blocks an age-related protein restored cartilage in aging and injured joints by reprogramming existing cells ...

Lenacapavir, a long-acting injectable form of HIV prevention, is set to revolutionise HIV prevention strategies in South ...